GO:0071602 phytosphingosine biosynthetic process: Sphingolipid Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071602 describes the biosynthesis of phytosphingosine, a long-chain sphingoid base with a 4-hydroxyl group.
• Phytosphingosine is a key precursor for complex sphingolipids in skin and is produced by gut microbiota.
• The pathway involves conserved enzymes such as serine palmitoyltransferase, 3-ketodihydrosphingosine reductase, and phytosphingosine hydroxylases.
• Phytosphingosine has anti-inflammatory and anticancer properties, and its dysregulation is linked to metabolic disorders and cancer.
• CRISPR-based models (KO, point mutation, knock-in, overexpression) enable functional dissection of phytosphingosine biosynthetic genes.
• Targeting this pathway offers therapeutic potential for skin barrier repair, colitis, and gastric cancer.
Description
Phytosphingosine biosynthetic process (GO:0071602) is a biological process defined as the chemical reactions and pathways resulting in the formation of phytosphingosine, (2S,3S,4R)-2-aminooctadecane-1,3,4-triol. Phytosphingosine is a sphingoid base characterized by a hydroxyl group at the C4 position, distinguishing it from sphingosine and dihydrosphingosine. This molecule serves as a precursor for complex sphingolipids, including phytoceramides, which are essential components of the stratum corneum and contribute to skin barrier function. The pathway is conserved across eukaryotes and some bacteria, and its products are increasingly recognized for their roles in cell signaling, immune modulation, and host-microbe interactions. Understanding this biosynthetic process is critical for researchers studying sphingolipid metabolism, skin biology, cancer, and metabolic diseases.
phytosphingosine biosynthetic process At A Glance
| GO ID | GO:0071602 |
|---|---|
| GO term | phytosphingosine biosynthetic process |
| Ontology | biological_process |
| Synonym | phytosphingosine anabolism, phytosphingosine biosynthesis, phytosphingosine formation, phytosphingosine synthesis |
| Major function | Production of phytosphingosine, a precursor for complex sphingolipids |
| Key enzymes | Serine palmitoyltransferase, 3-ketodihydrosphingosine reductase, phytosphingosine hydroxylase |
| Subcellular location | Endoplasmic reticulum and associated membranes |
| Pathway context | Sphingolipid metabolism |
What Is GO:0071602?
The phytosphingosine biosynthetic process (GO:0071602) encompasses the enzymatic steps that convert simple precursors into phytosphingosine, a sphingoid base with a 4-hydroxyl group. This process typically begins with the condensation of serine and palmitoyl-CoA, followed by reduction and hydroxylation reactions to yield the final product.
Why Is phytosphingosine biosynthetic process Important in Cell Biology?
Phytosphingosine biosynthetic process is important because phytosphingosine and its derivatives are critical for skin barrier integrity, immune regulation, and cellular signaling. Dysregulation of this pathway has been implicated in metabolic disorders, inflammatory diseases, and cancer, making it a target for therapeutic intervention.
• Maintains skin barrier function by contributing to ceramide synthesis.
• Modulates immune responses and inflammation in the gut.
• Exhibits anticancer activity in gastric cancer models.
• Influences metabolic health and predisposition to metabolic disorders.
• Plays a role in microbiota-host interactions.
• Serves as a biomarker for embryo quality in IVF.
• Linked to cellular senescence and musculoskeletal regeneration.
• Provides targets for CRISPR-based functional studies.
What Happens During phytosphingosine biosynthetic process?
Initiation: Serine Palmitoyltransferase Condensation
In simple terms: The first step combines two building blocks to form a new molecule.
The pathway begins with the condensation of L-serine and palmitoyl-CoA by serine palmitoyltransferase (SPT), forming 3-ketodihydrosphingosine (KDS). This reaction is rate-limiting and requires pyridoxal 5'-phosphate as a cofactor.
Reduction: 3-Ketodihydrosphingosine Reductase
In simple terms: A chemical group is removed to create a more stable intermediate.
KDS is reduced by 3-ketodihydrosphingosine reductase (KDSR) to dihydrosphingosine (sphinganine) in an NADPH-dependent manner.
Hydroxylation: Phytosphingosine Formation
In simple terms: An oxygen atom is added to the molecule to produce the final product.
Dihydrosphingosine is hydroxylated at the C4 position by a phytosphingosine hydroxylase (e.g., in yeast, Sur2; in mammals, a yet-fully-defined enzyme) to yield phytosphingosine. This step may involve cytochrome P450 or dioxygenase activity.
Subcellular Compartmentalization
In simple terms: The reactions occur in specific parts of the cell.
The biosynthetic steps are localized to the endoplasmic reticulum (ER) and possibly ER-associated membranes, where sphingolipid enzymes are enriched.
Key Genes Involved in GO:0071602 phytosphingosine biosynthetic process
The following genes and proteins are experimentally implicated in phytosphingosine biosynthesis or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SPTLC1 | Subunit of serine palmitoyltransferase | Rate-limiting enzyme; mutations cause HSAN1 |
| SPTLC2 | Subunit of serine palmitoyltransferase | Catalytic subunit; target for KO studies |
| SPTLC3 | Subunit of serine palmitoyltransferase | Tissue-specific regulation |
| KDSR | 3-ketodihydrosphingosine reductase | Reduction step; mutations cause erythrokeratodermia |
| SUR2 | Phytosphingosine hydroxylase (yeast) | C4 hydroxylation; model for enzyme discovery |
| CERS2 | Ceramide synthase | Uses phytosphingosine as substrate |
| CERS4 | Ceramide synthase | Phytoceramide synthesis |
| DEGS1 | Dihydroceramide desaturase | May influence phytosphingosine levels |
| ORMDL1 | Negative regulator of SPT | Regulates flux through pathway |
| ORMDL2 | Negative regulator of SPT | Homeostasis of sphingolipids |
| ORMDL3 | Negative regulator of SPT | Asthma susceptibility gene |
| SPTSSA | SPT small subunit | Stabilizes SPT complex |
| SPTSSB | SPT small subunit | Regulates SPT activity |
| ASAH1 | Acid ceramidase | Degrades phytoceramide to phytosphingosine |
| ACER1 | Alkaline ceramidase | Phytosphingosine generation |
| ACER2 | Alkaline ceramidase | Phytosphingosine generation |
| ACER3 | Alkaline ceramidase | Phytosphingosine generation |
| SGMS1 | Sphingomyelin synthase | Uses phytoceramide |
How Is phytosphingosine biosynthetic process Regulated?
The phytosphingosine biosynthetic process is regulated at multiple levels. Serine palmitoyltransferase (SPT) is feedback-inhibited by sphingolipids and regulated by ORMDL proteins. Transcriptional regulation of SPTLC subunits and KDSR responds to cellular stress and nutrient status. Additionally, microbiota-derived metabolites can influence phytosphingosine levels in the gut.
phytosphingosine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SPTLC1 | Hereditary sensory neuropathy | Knock-in mouse, iPSC-derived neurons |
| KDSR | Erythrokeratodermia variabilis | KO keratinocytes, skin equivalents |
| SUR2 | Phytosphingosine deficiency (yeast) | Yeast KO, overexpression |
| CERS2 | Cancer, metabolic disorders | KO cell lines, xenografts |
| ORMDL3 | Asthma, IBD | KO mice, airway epithelial cells |
Metabolic Disorders
Decreased levels of Flavonifractor plautii and its product phytosphingosine are associated with phlegm-dampness constitution and predisposition to metabolic disorders. This suggests that phytosphingosine biosynthesis in the gut microbiome contributes to metabolic homeostasis.
Inflammatory Bowel Disease
Phytosphingosine alleviates DSS-induced colitis by regulating gut microbiota and inflammatory responses. Thus, enhancing phytosphingosine biosynthesis could be therapeutic for IBD.
Cancer
Phytosphingosine suppresses gastric cancer through the SFRP4/β-catenin axis-mediated inhibition of Wnt signaling. In addition, microbiota-mediated upregulation of HLA class I by phytosphingosine sensitizes cancer cells to immune checkpoint inhibitors.
Skin Barrier Dysfunction
Topical supplementation with physiological lipids including phytosphingosine rebalances the stratum corneum ceramide profile and strengthens skin barrier function in adults predisposed to atopic dermatitis.
From phytosphingosine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SPTLC1 mutation affect phytosphingosine levels? | Point mutation knock-in in HEK293T |
| What is the role of KDSR in skin barrier? | Keratinocyte-specific KO mouse |
| Can phytosphingosine biosynthesis be enhanced? | Overexpression of SPT subunits in CHO cells |
| How does microbiota-derived phytosphingosine affect colitis? | Germ-free mice colonized with Flavonifractor plautii |
| Does phytosphingosine inhibit Wnt signaling? | Gastric cancer organoids with CRISPR KO of SFRP4 |
| What is the subcellular localization of phytosphingosine enzymes? | Tagged knock-in of KDSR with GFP |
How to Study the phytosphingosine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Phytosphingosine levels | Quantification in cells/tissues |
| RNA-seq | Gene expression changes | Pathway regulation studies |
| Western blot | Protein expression | Validation of KO/overexpression |
| SPT activity assay | Enzyme activity | Functional characterization |
| CRISPR screen | Gene essentiality | Discovery of novel regulators |
| Immunofluorescence | Subcellular localization | ER localization of enzymes |
| Flow cytometry | Cell surface markers | Immune response studies |
Metabolomics and Lipidomics
Mass spectrometry-based lipidomics enables quantification of phytosphingosine and its intermediates in cells and tissues. This method is essential for validating CRISPR KO effects on the pathway.
Transcriptomics and RNA-seq
RNA-seq can reveal changes in expression of sphingolipid genes upon genetic perturbation or treatment.
Proteomics and Enzyme Activity Assays
Western blotting and activity assays for SPT, KDSR, and hydroxylases confirm protein levels and catalytic function.
CRISPR Screening
Genome-wide CRISPR screens can identify novel regulators of phytosphingosine biosynthesis by selecting for resistance or sensitivity to pathway inhibitors.
How CRISPR Can Be Used to Study GO:0071602 phytosphingosine biosynthetic process
Knockout
CRISPR knockout of SPTLC1, KDSR, or CERS2 abolishes phytosphingosine production, enabling studies of its role in cell proliferation, differentiation, and stress responses.
Point Mutation
Introducing disease-associated point mutations (e.g., in SPTLC1) via CRISPR base editing or HDR allows modeling of hereditary sensory neuropathy and assessing effects on phytosphingosine biosynthesis.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous KDSR or SUR2 loci enables live-cell imaging of enzyme localization and dynamics.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of SPT subunits and hydroxylases boosts phytosphingosine production for therapeutic or biotechnological applications.
How EDITGENE Supports phytosphingosine biosynthetic process Research
Researchers studying phytosphingosine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in the pathway, and CRISPR-based models provide the most direct approach.
Contact EDITGENE today to design your custom CRISPR model for phytosphingosine biosynthetic process research.
Frequently Asked Questions About phytosphingosine biosynthetic process
What is phytosphingosine biosynthetic process?
It is the biological process (GO:0071602) that produces phytosphingosine, a sphingoid base with a 4-hydroxyl group, from serine and palmitoyl-CoA.
What genes are involved in phytosphingosine biosynthetic process?
Key genes include SPTLC1, SPTLC2, SPTLC3, KDSR, and SUR2, as well as ceramide synthases like CERS2 and CERS4.
What is the function of phytosphingosine?
Phytosphingosine is a precursor for complex sphingolipids, contributes to skin barrier function, and has anti-inflammatory and anticancer properties.
How is phytosphingosine biosynthetic process regulated?
It is regulated by feedback inhibition of serine palmitoyltransferase by sphingolipids and by ORMDL proteins.
What diseases are associated with phytosphingosine biosynthetic process?
Dysregulation is linked to metabolic disorders, inflammatory bowel disease, gastric cancer, and skin barrier defects.
Can CRISPR be used to study phytosphingosine biosynthetic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of pathway genes.
What methods are used to measure phytosphingosine?
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for quantification.
Is phytosphingosine found in humans?
Yes, phytosphingosine is present in human skin and gut, and can be produced by microbiota.
What is the role of phytosphingosine in cancer?
Phytosphingosine suppresses gastric cancer via SFRP4/β-catenin axis and sensitizes cancer cells to immune checkpoint inhibitors.
How can I create a knockout of SPTLC1?
EDITGENE provides custom CRISPR knockout services for SPTLC1 and other sphingolipid genes.
Conclusion
Phytosphingosine biosynthetic process (GO:0071602) is a fundamental pathway with growing relevance to skin biology, immunology, and cancer. Understanding its regulation and genetic basis offers opportunities for therapeutic intervention. CRISPR-based models and multi-omics approaches are essential tools for advancing this field.
References
- 1. Gault CR et al.. 2010. An overview of sphingolipid metabolism: from synthesis to breakdown.. Adv Exp Med Biol 688:1-23 PMID: 20919643
- 2. Andrew PV et al.. 2025. Topical supplementation with physiological lipids rebalances the stratum corneum ceramide profile and strengthens skin barrier function in adults predisposed to atopic dermatitis.. Br J Dermatol 193(4):729-740 PMID: 40408261
- 3. Li L et al.. 2025. A decrease in Flavonifractor plautii and its product, phytosphingosine, predisposes individuals with phlegm-dampness constitution to metabolic disorders.. Cell Discov 11(1):25 PMID: 40097405
- 4. Ferrari V et al.. 2023. Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I.. Cancer Cell 41(10):1717-1730.e4 PMID: 37738976
- 5. Xu J et al.. 2025. Association between Perfluorooctanoic Acid-Related Poor Embryo Quality and Metabolite Alterations in Human Follicular Fluid during IVF: A Cohort Study.. Environ Health Perspect 133(6):67017 PMID: 40334213
- 6. Yu J et al.. 2026. Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration.. Aging Cell 25(4):e70468 PMID: 41944220
- 7. Shan R et al.. 2025. Phytosphingosine alleviates DSS-induced colitis by regulating the gut microbiota and inflammatory responses.. Int Immunopharmacol 166:115610 PMID: 41027059
- 8. Liu Y et al.. 2025. Phytosphingosine suppresses gastric cancer through SFRP4/β-catenin axis-mediated Wnt signaling pathway inhibition.. Chem Biol Interact 421:111749 PMID: 40983245
